Who owns BRIACELL THERAPEUTICS CORP?

Tip: Access positions for across all investors

Analyze quarterly positions in Briacell Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Briacell Therapeutics Corp stock

Who bought or sold BRIACELL THERAPEUTICS CORP this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Lynwood Capital Management 1.6M $4.6M 1% Mar 2024
 View chart
Susquehanna International 161k $459k 39% Mar 2024
 View chart
Bank Of Montreal 134k $522k 148% Mar 2024
 View chart
Redmond Asset Management 133k $381k 0% Mar 2024
 View chart
K.J. Harrison & Partners 87k $249k 8% Mar 2024
 View chart
Caption Management 79k $226k 100% Mar 2024
 View chart
Onyx Bridge Wealth Group 50k $109k 67% Mar 2024
 View chart
Citadel Advisors 36k $102k 2% Mar 2024
 View chart
Summit Trail Advisors 35k $100k 0% Mar 2024
 View chart
Morgan Stanley 24k $68k -75% Mar 2024
 View chart
Bank of America Corporation 18k $52k 1% Mar 2024
 View chart
HighTower Advisors 15k $41k -9% Mar 2024
 View chart
TD Waterhouse Canada 12k $41k 0% Mar 2024
 View chart
Concord Wealth Partners 11k $31k 0% Mar 2024
 View chart
National Bank Of Canada /fi/ 7.5k $40k 200% Dec 2023
 View chart
Royal Bank of Canada 3.6k $10k -81% Mar 2024
 View chart
Advisor Group Holdings 1.0k $3.0k 8500% Mar 2024
 View chart
Tower Research Capital 787.00 $2.3k 49% Mar 2024
 View chart

Who sold out of Briacell Therapeutics Corp?

Fund or Company Name Date Sold Shares Held Valued At
Daniel D. Thurber Dec 2023 267k $1.6M
Torno Capital Dec 2023 223k $1.3M
Natixis Sep 2023 96k $597k
K2 Principal Fund Sep 2023 25k $156k
Simplex Trading Dec 2023 13k $73k